Form 8-K - Current report:
SEC Accession No. 0001193125-14-226853
Filing Date
2014-06-05
Accepted
2014-06-05 14:12:02
Documents
3
Period of Report
2014-05-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d736465d8k.htm 8-K 14867
2 EX-10.1 d736465dex101.htm EX-10.1 4097
3 GRAPHIC g736465img1.jpg GRAPHIC 170392
  Complete submission text file 0001193125-14-226853.txt   254986
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23186 | Film No.: 14893270
SIC: 2836 Biological Products, (No Diagnostic Substances)